Disparities in Time to Treatment for Breast Cancer: Existing Knowledge and Future Directions in the COVID-19 Era

Fasano, Genevieve A.; Bayard, Solange; Gillot, Tamika; Hannibal, Zuri; Pedreira, Marian; Newman, Lisa A.

doi:10.1007/s12609-022-00469-9

Cited by 4 publications

(1 citation statement)

References 35 publications

(35 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Their study also assessed the influence of the location, type of institution (academic vs. community), and travel distance to the treatment facility and found that the lowest rate of BCT use happened in community cancer centers and among patients who traveled distances to their facility greater than 27.8 km, the latter suggesting that access to standard radiotherapy in urban vs. rural areas is variable and directly influences the use of BCT. A multitude of studies have demonstrated delays in time to treatment, including time to surgery by race [148,149]. In fact, a National Cancer Database Study by Jackson et al showed that 30.6% of non-Hispanic Black women had surgery more than 60 days after diagnosis compared to only 18% of White women [150].…”

Section: Surgical Treatmentmentioning

confidence: 99%

Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity

Wilkerson,

Gentle,

Ortega

et al. 2024

Healthcare

View full text Add to dashboard Cite

Breast cancer survival has increased significantly over the last few decades due to more effective strategies for prevention and risk modification, advancements in imaging detection, screening, and multimodal treatment algorithms. However, many have observed disparities in benefits derived from such improvements across populations and demographic groups. This review summarizes published works that contextualize modern disparities in breast cancer prevention, diagnosis, and treatment and presents potential strategies for reducing disparities. We conducted searches for studies that directly investigated and/or reported disparities in breast cancer prevention, detection, or treatment. Demographic factors, social determinants of health, and inequitable healthcare delivery may impede the ability of individuals and communities to employ risk-mitigating behaviors and prevention strategies. The disparate access to quality screening and timely diagnosis experienced by various groups poses significant hurdles to optimal care and survival. Finally, barriers to access and inequitable healthcare delivery patterns reinforce inequitable application of standards of care. Cumulatively, these disparities underlie notable differences in the incidence, severity, and survival of breast cancers. Efforts toward mitigation will require collaborative approaches and partnerships between communities, governments, and healthcare organizations, which must be considered equal stakeholders in the fight for equity in breast cancer care and outcomes.

show abstract

Section: Surgical Treatmentmentioning

confidence: 99%

Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity

Wilkerson,

Gentle,

Ortega

et al. 2024

Healthcare

View full text Add to dashboard Cite

show abstract

Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers

Lee,

Gonzalez,

Geiss

et al. 2024

J Cancer Surviv

View full text Add to dashboard Cite

Purpose Adherence to oral endocrine therapy (ET) remains an issue for up to half of women prescribed these medications. There is emerging data that Black breast cancer survivors (BCS) have lower rates of ET adherence. Given the disparities in breast cancer recurrence and survival for Black BCS compared to their White counterparts, the goal of this study is to better understand barriers to ET adherence among Black BCS from the patient and provider perspectives. Methods In this qualitative study, we conducted semi-structured interviews between October 29, 2021, and March 1, 2023. Interviews were recorded and transcribed, and coded data were organized into primary and secondary themes. Participants were recruited from a single academic cancer center. A convenience sample of 24 Black BCS and 9 medical oncology providers was included. Eligible BCS were 18 years or older, English-speaking, diagnosed with stage I–III hormone receptor-positive breast cancer, who had initiated ET. Results Mean age of the BCS was 55 years (interquartile range, IQR 17 years). About one-fourth had a high school diploma or less (26.1%) and 47% completed a college education or higher. Approximately one-third of participants had annual household incomes of $40,000 or less (30.4%) or more than $100,000 (30.4%). Forty-three percent of the patient participants had private insurance; 11% were insured through Medicaid or the federal healthcare exchange; 26.1% had Medicare; and 13% were uninsured. Of the 9 medical oncology providers interviewed, 2 were advanced practice providers, and 7 were medical oncologists. We found 3 major themes: (1) Black BCS often had concerns about ET before initiation; (2) after initiation, both BCS and providers reported side effects as the most impactful barrier to ET adherence; and (3) survivors experienced challenges with managing ET side effects. Conclusions Our results suggest that multifaceted support interventions for managing ET-related symptoms may lead to improved adherence to ET among Black women and may reduce disparities in outcomes. Implications for Cancer Survivors Multifaceted support interventions for managing ET-related symptoms may lead to improved adherence to ET among Black breast cancer survivors.

show abstract

Disparities in Hormone Receptor-Positive Breast Cancer

Ogayo,

Mittendorf,

Kantor

2024

Curr Breast Cancer Rep

View full text Add to dashboard Cite

Disparities in Time to Treatment for Breast Cancer: Existing Knowledge and Future Directions in the COVID-19 Era

Cited by 4 publications

References 35 publications

Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity

Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity

Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers

Disparities in Hormone Receptor-Positive Breast Cancer

Contact Info

Product

Resources

About